Human skin microbiology specialist Labskin has built an articial intelligence (AI) psoriasis skin model that enables cosmetic rms to test and bring to market products targeting this skin condition.
Part of Dublin-headquartered Integumen, Labskin’s model was created by cloning multiple skin samples from 671 anonymised patients – from the psoriasis lesion and other skin sites – resulting in more than 2,000 samples. Using genome sequencing and dierent articial intelligence algorithms, Labskin then identied 216 species of microbiota, 33 of which were common across all
psoriasis suerers.
Speaking to CosmeticsDesign-Europe, Integumen CEO Gerard Brandon said this knowledge empowered cosmetics companies to develop ecient disease-targeted products faster.
“Everybody who has psoriasis knows they have it, but this is the rst time you have a virtual model of what psoriasis is,” Brandon said. “…Now, we can conduct tests on diseased skin and look at how the product balances the microbiome, and that’s a huge additional category.”
Facilitating the development of new products with proven ecacy opened up great promise for the cosmetics category, he said, but also retailers and drugstores struggling with falling footfall and looking for ways to dierentiate.
Follow us on Linkedin!